Treatment of advanced lung cancer by external beam radiotherapy and high dose rate (HDR) brachytherapy
| Autor: | Krzysztof Świerkocki, Witold Młynarczyk, Janusz Skowronek, Grzegorz Zwierzchowski, K. Adamska, Tomasz Piorunek, Szczepan Cofta |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Cancer Research
medicine.medical_specialty teletherapy Palliative treatment business.industry medicine.medical_treatment brachytherapy Brachytherapy medicine.disease External beam irradiation lung cancer Oncology Radiology Nuclear Medicine and imaging Total dose medicine Radiology Nuclear Medicine and imaging External beam radiotherapy Radiology Stage (cooking) Lung cancer business Dose rate |
| Zdroj: | Reports of Practical Oncology & Radiotherapy. 6:99-105 |
| ISSN: | 1507-1367 |
| DOI: | 10.1016/s1507-1367(01)70466-x |
| Popis: | Purpose Brachytherapy is a highly valued and effective palliative treatment for lung cancer, especially as it reduces intensity of dyspnoea and other symptoms arising from tumours inside the respiratory tract. In some cases, due to the location of the lesion brachytherapy is a treatment of choice. However, its curative role is unclear. A combination treatment of brachytherapy and an external beam irradiaton may play a significant role when the mediastinal lymph nodes are involved. The paper presents the results of treatment of advanced lung cancer patients by external beam irradiation and brachytherapy, and the role of this palliative treatment is discussed. Material and methods Between May 1999 and March 2000 at the Greatpoland Cancer Centre fifteen patients with advanced lung cancer were treated by HDR brachytherapy and palliative external beam irradiation using the method of hypofractionation. The patients’ age ranged between 39 to 80 years, mean: 54.3 years. The treatment consisted of external beam irradiation (total dose of 20–30 Gy), and a weekly high dose rate (HDR) brachytherapy (three fractions of 7.5 or 10 Gy, at 1 cm from the source). In three cases the treatment was started with external irradiation, whereas in 12 cases the first stage was brachytherapy. During the patients’ clinical and endobronchial follow-up of 1, 3 and 6 months, local remission and regression of difficulties in breathing, cough, pain and haemoptysis were assessed. Results In all our patients subjective improvement (regression of all symptoms) was found on the first check-up following treatment. In one case complete remission of the tumour lasted for over 6 months, in 9 cases partial remission and in two cases progression were found. Severe complications due to the high total local dose were not observed. Conclusions Combined palliative treatment (intraluminal brachytherapy and external beam irradiation) in advanced lung cancer was an efficient method that led to regression of symptoms and improvement of well-being in many patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|